Although the difference of TIGIT expression on NK cells was not statistically significant, the expression of the activating receptor DNAM-1, which shares the same ligands as inhibitory TIGIT, was downregulated on CD56dim NK cells in the AML patients (Figure 1H). Here, TIGIT is linked to acute myeloid leukemia.